Abingdon Health PLC (GB:ABDX) has released an update.
Abingdon Health PLC, a prominent lateral flow contract development and manufacturing organization, has reported its total voting rights count as of May 31, 2024, to be 126,716,822 ordinary shares, with no treasury shares held. The company specializes in rapid test development across various sectors, including clinical and environmental testing, and also operates an e-commerce platform for self-testing products. Abingdon Health continues to support industries requiring quick decision-making through their innovative rapid testing solutions.
For further insights into GB:ABDX stock, check out TipRanks’ Stock Analysis page.
